Clinical Trial Update: TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a tailored therapeutic regimen for women with preterm premature rupture of membranes to prolong pregnancy and improve maternal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Premature Rupture of Membranes

Snippet

Sponsor: The Central and Eastern European Gynecologic Oncology Group | Conditions: Preterm Premature Rupture of Membranes (PPROM) | Phase 3 | Status: RECRUITING